Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Frontiers in Oncology
|
July 28, 2022
Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study
Jingjing Ma, Zhiguang Lin, Tianling Ding, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
July 6, 2024
Prognostic Assessment in Patients With Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Using MRI-Based Radiomics
Jianpeng Liu, Jiaqi Tu, Bin Hu, et al.
Oncotarget
|
September 9, 2017
Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma
Ni Fan, Lu Zhang, Xiaoping Xu, et al.
Frontiers in Immunology
|
May 20, 2024
Case report: BTK inhibitors is effective in type II mixed cryoglobulinemia with wild-type MyD88
Mingyue Xu, Yunyu Xu, Li Yuan, et al.
Oncology Reports
|
October 16, 2018
Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma
Lin Zhuang, Jie Lai, Kun Chen, et al.
Biomaterials
|
August 11, 2016
Functional engineered human cardiac patches prepared from nature's platform improve heart function after acute myocardial infarction
Qingjie Wang, Hui Yang, Aobing Bai, et al.
Neoplasia (New York, N.Y.)
|
December 29, 2024
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma
Shu Wang, Hong Chen, Bo Dai, et al.
Journal of Hematology & Oncology
|
June 18, 2026
BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88<sup>L265P</sup>-induced PIM1 stability
Yan Yuan, Bo Dai, Haoshu Zhong, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Frontiers in Oncology
|
July 28, 2022
Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study
Jingjing Ma, Zhiguang Lin, Tianling Ding, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
July 6, 2024
Prognostic Assessment in Patients With Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Using MRI-Based Radiomics
Jianpeng Liu, Jiaqi Tu, Bin Hu, et al.
Oncotarget
|
September 9, 2017
Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma
Ni Fan, Lu Zhang, Xiaoping Xu, et al.
Frontiers in Immunology
|
May 20, 2024
Case report: BTK inhibitors is effective in type II mixed cryoglobulinemia with wild-type MyD88
Mingyue Xu, Yunyu Xu, Li Yuan, et al.
Oncology Reports
|
October 16, 2018
Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma
Lin Zhuang, Jie Lai, Kun Chen, et al.
Biomaterials
|
August 11, 2016
Functional engineered human cardiac patches prepared from nature's platform improve heart function after acute myocardial infarction
Qingjie Wang, Hui Yang, Aobing Bai, et al.
Neoplasia (New York, N.Y.)
|
December 29, 2024
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma
Shu Wang, Hong Chen, Bo Dai, et al.
Journal of Hematology & Oncology
|
June 18, 2026
BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88<sup>L265P</sup>-induced PIM1 stability
Yan Yuan, Bo Dai, Haoshu Zhong, et al.
Page
of 3